EUnetHTA and the HTA Network

Home  /  About EUnetHTA  /  EUnetHTA and the HTA Network

EUnetHTA performs the function of the scientific and technical cooperation of the HTA Network.

The Directive 2011/24/EU on the application of patients’ rights in cross-border healthcare was adopted in 2011 and stipulates (Article 15) that the Union shall support and facilitate cooperation between national authorities or bodies responsible for health technology assessment designated by the Member States. According to the Implementing Decision, the HTA Network is to be supported by a scientific and technical cooperation to meet the objectives of the European cooperation on HTA as per Article 15 of the Directive.

EUnetHTA’s specific role as the scientific and technical cooperation on HTA in Europe

Joint Action 3 (JA3)

The activities of the EUnetHTA JA3 are supported by funding from the European Union in the framework of the Health Programme. This joint action will increase the use, quality and efficiency of joint HTA work at European level.  EUnetHTA will support evidence-based, sustainable and equitable choices in healthcare and health technologies and support re-use in regional and national HTA reports and activities. The strategic objectives of the EUnetHTA JA3 are:

  • To develop a voluntary, sustainable European Collaboration on HTA, the model focusses on  supporting Members States in receiving HTA relevant information that is- objective, reliable, timely, comparable.
  • The collaborative production of structured HTA core information, including rapid HTA’s will be decentralised, methodologies and production related information and communication technology infrastructure will be finalised as stand alone support network from 2020 onwards.

The EUnetHTA JA3 will build on the lessons, success and products of the earlier EUnetHTA Joint Actions. The EUnetHTA collaboration has grown to 80+ organisations from 30 countries.  A network of strong partners across Europe working together for better access to health technologies for European citizens.

Joint Action 2 (JA2)

The activities of the EUnetHTA JA2 are supported by funding from the European Union in the framework of the Health Programme. The content and objectives of the EUnetHTA JA2 activities are defined by the EUnetHTA JA2 Grant Agreement with the European Commission and laid out in detail in the EUnetHTA JA2 3-year Work Plan. The strategic objectives of the EUnetHTA JA2 are:

  • To strengthen the practical application of tools and approaches to cross-border HTA collaboration
  • To bring collaboration to a higher level resulting in better understanding for the Commission and Member States of the ways to establish a sustainable structure for HTA in the EU
  • To develop a general strategy, principles and an implementation proposal for a sustainable European HTA collaboration according to the requirements of Article 15 of the Directive for cross-border healthcare.

Contact Information

For more information on the HTA Network, please contact the HTA Network Secretariat at:
SANCO-HTA-NETWORK@ec.europa.eu or visit the HTA Network website.

EUnetHTA Partner Organisations and Institutions

Austria

GOG
Gesundheit Österreich GmbH/Geschäftsbereich

HVB
Hauptverband der Österreichischen Sozialversicherungsträger (Association of Austrian Social Insurance Institutions)

LBI-HTA
Ludwig Boltzmann Institute for Health Technology Assessment

UMIT
University for Health Sciences, Medical Informatics and Technology

Belgium

IPH
Scientific Institute of Public Health

KCE
Belgian Health Care Knowledge Centre

RIZIV-INAMI
Rijksinstituut voor Ziekte- en Invaliditeitsverzekering

Bulgaria

NCPHA
National Center of Public Health and Analyses

Croatia

AAZ
Agency for Quality and Accreditation in Health Care and Social Welfare

CHIF
Croatian Health Insurance Fund

CIPH
Croatian Institute of Public Health

Cyprus

MoH Cyprus
Ministry of Health of Cyprus

Czech Republic

MoH Czech
Ministry of Health of the Czech Republic

SUKL
State Institute for Drug Control

Denmark

DEFACTUM (formerly CFK)
DEFACTUM

Estonia

UTA
Institute of Family Medicine and Public Health

Finland

FIMEA
Finnish Medicines Agency

THL
National Institute for Health and Welfare

France

HAS
French National Authority for Health (Haute Autorité de Santé)

Germany

DIMDI
German Institute for Medical Documentation and Information

GBA
Gemeinsamer Bundesausschuss

IQWIG
Institute for Quality and Efficiency in Health Care

Greece

EKAPTY-NKUA
National and Kapodistrian University of Athens

EKAPTY SA
National Evalution Center of Quality and Technology in S.A.- EKAPTY

EOF
National Organization for Medicines

EOPPY
National Organisation for Healthcare Provision

IFET
Institute of Pharmaceutical Research and Technology

OCSC
Onassis Cardiac Surgery Centre

Hungary

NIPN
National Institute of Pharmacy and Nutrition

SU
Health Services Management Training Center

Ireland

HIQA
Health Information and Quality Authority

NCPE
National Centre for Pharmacoeconomics, St. James Hospital

Italy

Agenas
National Agency for Regional Health Services

AIFA
Italian Medicines Agency

CRUF/AOUIVR
Centro Regionale Unico sul Farmaca del Veneta

DGFDM IT
Sede del Ministro – Ministero della salute

RER
Regione Emilia-Romagna

UCSC GEMELLI
University Hospital A. Gemelli

UVTA/AOP
Unita di Valutazione Technology Assessment

Veneto/CRUF
Regione Del Veneto – Area Sanita E’ Sociale

Latvia

NVD
National Health Service

Lithuania

HI
The Institute of Hygiene

VASPVT
State Health Care Accreditation Agency

Malta

DPA/MoH Malta
Directorate for Pharmaceutical Affairs

Netherlands

EUR
Erasmus Universiteit Rotterdam

UU
Utrecht University

ZIN
National Health Care Institute

Norway

Hdir
Norwegian Directorate of Health

NIPHNO (formerly NOKC)
The Norwegian Institute of Public Health

NOMA
Norwegian Medicines Agency

Poland

AOTMiT
Agency for Health Technology Assessment and Tariff System

Portugal

ACSS IP
Administração Central do Sistema de Saúde, I.P.

INFARMED
National Authority of Medicines and Health Products

Romania

NIPHB
Institutu National De Sanatate Publica (INSP)

NSPHMPDB
National School of Public Health, Management and Professional Development

UBB
Babes-bolayi University, Cluj School of Public Health

Slovakia

MoH Slovak Republic
Ministry of Health of the Slovak Republic

UniBA FOF
Comenius University in Bratislava

Slovenia

JAZMP
Public Agency of the Republic of Slovenia for Medicinal Products and Medical Devices

NIJZ
National instute of Public Health (NIJZ)

Spain

AEMPS
Agencia Española de Medicamentos y Productos Sanitarios

AETS-ISCIII
The Instituto De Salud Carlos III

AETSA
Andalusian HTA Agency

AQuAS
Agency for Health Quality and Assessment of Catalonia

AVALIA FNS
Fundacion Profesor Novoa Santos

AVALIA-T
Galician Agency for HTA

BIOEF
Basque Foundation for Health Innovation and Research

DGFPS MSPSI
Directorate General for Pharmacy and Health Care Products

FPS
Fundación Pública Andaluza Progreso y Salud

Funcanis
Fundación Canaria de Investigación Sanitaria

Osteba
Basque Office for Health Technology Assessment- Ministry for Health

SESCS
Evaluation AND Planning Unit – Directorate of the Canary Islands Health Service

Sweden

MPA
Medical Products Agency

SBU
Swedish Agency for Health Technology Assessment and Assessment of Social Services

TLV
Dental and Pharmaceutical Benefits Agency

Switzerland

SNHTA
Swiss Network for HTA

United Kingdom

AWTTC
All Wales Therapeutics and Toxicology Centre

HIS
Healthcare Improvement Scotland

NICE
National Institute for Health and Care Excellence